Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

New MAP4K4 inhibitors identified for suppressing cardiac muscle cell death

Sep. 9, 2021

Altered Chkb leads to cardiomyopathy, murine model shows

Sep. 6, 2021

New pyrimidinone amides as APJ receptor agonists identified for heart failure

Sep. 6, 2021

QGC-606 prevents LV dysfunction in mice post-MI

Sep. 3, 2021

Loss of fbn2b tied to cardiovascular manifestations overlapping with Marfan syndrome

Sep. 1, 2021

New heart failure animal model also captures arrhythmia susceptibility

Aug. 31, 2021

Increased atrial proarrhythmic activity seen in murine model of OSA

Aug. 31, 2021

Stressed fat cells send mitochondria to teach heart cells self-defense

Aug. 27, 2021

FDA clears IND for phase II study of CardiolRx for acute myocarditis

Aug. 25, 2021

Pirfenidone shows favorable effects in patients with HFpEF

Aug. 18, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...